(Q83186350)
Statements
Additive cytotoxic effect of bortezomib in combination with anti-CD20 or anti-CD52 monoclonal antibodies on chronic lymphocytic leukemia cells (English)
Tadeusz Robak
Piotr Smolewski
Olga Grzybowska-Izydorczyk
Markus Duechler
Anna Linke
Barbara Cebula